Current Clinical Trials

A Reliable Resource

The clinical trials listed below are official trials listed on the website, a US federally sponsored collaboration between the Food and Drug Administration (FDA) and the National Library of Medicine (NLM) section of the National Institutes of Health (NIH). The sponsor of a clinical trial is obligated by law to include accurate information including registration information, reporting of results and adverse events. Penalties exist for non-compliance.

Clinical Trail Phases

Phase I – New drug in a small group of people for safety, safe dose range and side effects

Phase II – Drug/treatment given to a larger group of people for efficacy and further safety evaluation

Phase III – Drug/treatment given to large group of people to confirm effectiveness, monitor       side effects, collect information before going to market. Confirmation here leads to seeking market approval for sale to the public at large.

Phase IV – After drug/treatment is on the market. Gathering of information on its effect in various populations and to study possible side-effects of long-term use.